Genky DrugStores Balance Sheet

Financials in millions JPY. Fiscal year is July - June.

Millions JPY. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 20, 2025	Jun '25 Jun 20, 2025	Jun '24 Jun 20, 2024	Jun '23 Jun 20, 2023	Jun '22 Jun 20, 2022	Jun '21 Jun 20, 2021
Cash & Equivalents	4,697	6,221	5,896	5,329	5,438	7,913
Cash & Short-Term Investments	4,697	6,221	5,896	5,329	5,438	7,913
Cash Growth	-32.35%	5.51%	10.64%	-2.00%	-31.28%	19.53%
Accounts Receivable	5,020	4,837	4,685	3,925	2,799	2,601
Other Receivables	-	2,575	2,406	2,259	2,014	1,816
Receivables	5,020	7,412	7,091	6,184	4,813	4,417
Inventory	28,776	27,071	24,028	22,490	20,911	19,389
Other Current Assets	3,545	506	319	410	352	421
Total Current Assets	42,038	41,210	37,334	34,413	31,514	32,140
Property, Plant & Equipment	85,058	79,203	69,936	65,104	59,260	52,527
Long-Term Investments	7,047	3,857	3,760	3,637	3,680	3,569
Other Intangible Assets	274	307	378	363	374	394
Long-Term Deferred Tax Assets	-	2,120	2,039	1,840	1,698	1,578
Other Long-Term Assets	3	2	2	1	1	1
Total Assets	134,420	127,326	113,939	105,912	97,118	90,795
Accounts Payable	28,113	26,732	24,188	22,192	20,564	19,616
Accrued Expenses	159	121	133	136	105	128
Short-Term Debt	1,228	-	-	-	-	-
Current Portion of Long-Term Debt	8,777	8,412	8,088	11,242	10,180	6,816
Current Portion of Leases	-	6	7	19	17	30
Current Income Taxes Payable	2,138	7,132	6,939	5,467	5,594	6,330
Other Current Liabilities	6,204	1,409	1,491	1,060	1,187	1,721
Total Current Liabilities	47,207	43,812	40,846	40,116	37,647	34,641
Long-Term Debt	25,223	25,817	22,408	20,946	20,754	21,684
Long-Term Leases	-	139	145	147	8	25
Other Long-Term Liabilities	4,347	4,131	3,861	4,023	2,477	2,281
Total Liabilities	76,777	73,899	67,260	65,232	60,886	58,631
Common Stock	1,054	1,035	1,024	1,010	1,008	1,000
Additional Paid-In Capital	6,716	6,451	6,440	6,426	6,424	6,415
Retained Earnings	50,356	46,534	39,862	33,917	29,531	25,479
Treasury Stock	-699	-790	-790	-789	-789	-789
Comprehensive Income & Other	216	197	143	116	58	59
Shareholders' Equity	57,643	53,427	46,679	40,680	36,232	32,164
Total Liabilities & Equity	134,420	127,326	113,939	105,912	97,118	90,795
Total Debt	35,228	34,374	30,648	32,354	30,959	28,555
Net Cash (Debt)	-30,531	-28,153	-24,752	-27,025	-25,521	-20,642
Net Cash Per Share	-1001.70	-924.42	-813.77	-889.27	-839.63	-679.35
Filing Date Shares Outstanding	30.48	30.4	30.38	30.37	30.37	30.35
Total Common Shares Outstanding	30.48	30.4	30.38	30.37	30.37	30.35
Working Capital	-5,169	-2,602	-3,512	-5,703	-6,133	-2,501
Book Value Per Share	1891.23	1757.70	1536.31	1339.57	1193.22	1059.62
Tangible Book Value	57,369	53,120	46,301	40,317	35,858	31,770
Tangible Book Value Per Share	1882.24	1747.60	1523.87	1327.62	1180.90	1046.64

Source: S&P Global Market Intelligence. Standard template. Financial Sources.